CASP1 and obesity due to melanocortin 4 receptor deficiency: Caspase-1 was also associated with the regulation of glucose and lipid metabolism [197], making it a potential target molecule in the treatment of metabolism-related disorders, such as obesity [198], diabetes or osteoarthritis [199], cancer, and non-alcoholic fatty liver disease [200].